Relmada Therapeutics (RLMD) EPS (2014 - 2026)
Relmada Therapeutics (RLMD) EPS from Sep 30, 2014 to Mar 31, 2026. The TTM Relmada Therapeutics (RLMD) EPS is -$1.05. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Relmada Therapeutics (RLMD) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -57.10% |
| 3 Years TTM | -27.90% |
| 5 Years TTM | -0.59% |
Annual EPS change of Relmada Therapeutics (RLMD)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.18 | -76.79% |
| 2025 | -$0.78 | -70.48% |
| 2024 | -$2.65 | -19.24% |
| 2023 | -$3.28 | -37.09% |
| 2022 | -$5.22 | +360.38% |
| 2021 | -$1.13 | +24.52% |
| 2020 | -$0.91 | +250.64% |
| 2019 | -$0.26 | -90.91% |
| 2018 | -$2.86 | +567.63% |
| 2017 | -$0.43 | +116.67% |
| 2016 | -$0.20 | +2180.08% |
| 2015 | -$0.00866 | -99.63% |
| 2014 | -$2.31 | N/A |
Comparison Relmada Therapeutics (RLMD) five years EPS CAGR with competitors
Relmada Therapeutics (RLMD) five years EPS CAGR is -0.59%.